Despite the growing body of evidence, our understanding of barriers to healthcare encountered by individuals with Autism Spectrum Disorder (ASD) remains limited, particularly beyond childhood and outside higher resource countries (HRCs).
Invigorating the Biopharmaceutical Sector’s Contribution to Canada’s Health Research and Innovation Ecosystem
Research Canada, in partnership with Shift Health, recently convened an Expert Advisory Panel to conduct an independent study examining the role of the biopharmaceutical industry within Canada’s health research and innovation ecosystem. The final report emphasizes that Canada needs an active and engaged biopharmaceutical sector if we are to realize the full health, social and economic potential of our health research and innovation ecosystem.
Our recently published Health Intelligence report, “Maximizing the Value of Cannabis-Based Pharmaceuticals,” examines how innovators can maximize the value of cannabis-based pharmaceuticals for patients, prescribers and payers.
Shift Health Webinar Report & Recording: “Embedding Inclusion, Diversity, Equity and Accessibility (IDEA) in Research-Intensive Organizations”
Building on our recently published Health Intelligence report on inclusion, diversity, equity and accessibility (IDEA), we convened an exceptional panel of leaders on October 22nd, 2020, for a webinar to discuss embedding IDEA in research-intensive organizations.
Longwoods Publication: “Fostering Clinical Research in the Community Hospital: Opportunities and Best Practices”
As we explore in our Longwoods publication, Fostering Clinical Research in the Community Hospital: Opportunities and Best Practices, clinical research can better position community hospitals to test and adopt cutting-edge products, and increase the cost-effectiveness and quality of care.
For research-intensive organizations, COVID-19 and our collective awakening to the insidious realities of racism have exposed the limitations of accepted approaches to inclusion, diversity, equity and accessibility.
We convened a virtual roundtable in collaboration with Life Sciences Ontario (LSO), featuring a diverse panel of leaders, on what COVID-19 is teaching us and how we can prepare our health research and innovation ecosystem for a resilient, productive and impactful future.
In our new report, COVID-19 and the Future of Health Research and Innovation, we argue that the pandemic represents an inflection point for the health research and innovation system. There has never been greater recognition that “science is the solution”. Therefore there has never been a more fertile moment to reinvigorate investment in health research and innovation and create the best system possible.
On February 6th, 2020, Shift Health facilitated a half-day workshop with over 100 stakeholders, including patients, healthcare providers, government, industry and researchers.